Zimbabwe has turned down a substantial US health deal valued at 367 million US dollars (272 million pounds) over five years due to Washington's demand for sensitive information.
The decision was revealed following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesperson has since stated that the United States was requesting genetic material for scientific study and commercial purposes while was not willing to share the benefits from future treatments.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for more negotiations to secure a deal acceptable to both sides so the country's critical HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a court halted a similar health funding agreement after concerns were filed about the security of Kenyans' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government deals to boost openness and accountability.
Based on reports, Sixteen nations in Africa have to date agreed to these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population should a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures already established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This framework is intended to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our US partners on how future collaboration could be designed in a manner that respects the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that negotiations should continue given that much of the country's HIV programmes depended on international support.
"Where technical issues exist, such as those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.
The situation emphasises the complex debate between accepting much-needed international aid and protecting local interests in an increasingly interconnected world.